MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Regulatory/Compliance / Food & Drug Administration (FDA) / Analyst says BSX may take CRM lead | Medtech Wall Street news for the week of September 29, 2014

Analyst says BSX may take CRM lead | Medtech Wall Street news for the week of September 29, 2014

October 2, 2014 By MassDevice Leave a Comment

Analyst: Boston Scientific could take CRM lead

September 25, 2014 by Alexander Soule

Analyst: Boston Scientific could take pacer lead

Boston Scientific might lack a truly leadless pacemaker, unlike rivals Medtronic and St. Jude Medical, but it still might be in the best position to gain share in the cardiac rhythm management market, according to Leerink Swann analyst Danielle Antalffy.

Traditional pacemakers are inserted adjacent to the heart and use “leads” to deliver impulses to maintain regular heartbeat. St. Jude acquired a “leadless” pacemaker when it acquired Nanostim in October 2013, with Medtronic seeking approval for its own Micra version of the the technology. Read more

Orthofix CFO bails after 6 months amid deepening financial fix

September 25, 2014 by Alexander Soule

Orthofix CFO bails after 6 months amid financial fix

Orthofix CFO Mark Heggestad is stepping down just 6 months into his tenure, even as the medical device company’s 3-year financial restatement yesterday deepened on new problems with its inventory controls.

Orthofix promoted its chief accounting officer Doug Rice to replace Heggestad, who took over May 9 from interim CFO David Ziegler. Longtime CFO Emily Buxton had been replaced in April after a decade as Orthofix’s financial chief. Heggestad, who is slated to stay on as an outside consultant, is leaving due to “personal circumstances,” Orthofix said. Read more

Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien

September 29, 2014 by Brad Perriello

Fourth time's the charm: pSivida, Alimera jump on FDA nod for Iluvien

After 3 rejections, the FDA approved the Iluvien diabetic macular degeneration drug/device treatment co-developed by Alimera Sciences and pSivida, sending both companies’ stock up today on Wall Street.

Iluvien, an injectable implant, was approved to treat DME, a swelling on the back of the retina that in the most severe cases can lead to blindness. It’s a tiny cylinder implanted in the back of the eye that’s designed to deliver small doses of a corticosteroid, fluocinolone acetonide, for 36 months. Read more

Echo Therapeutics is on the ropes

September 25, 2014 by Alexander Soule

Echo Therapeutics is on the ropes

After warning in August it had sufficient capital to last it only until November, Echo Therapeutics abruptly suspended operations, saying its cash resources will be drained by the end of September and raising the specter of a bankruptcy filing.

Philadelphia-based Echo Therapeutics has been developing a wireless system it calls Symphony for the continuous monitoring of blood glucose levels in hospitals.  Read more

Activist investor erupts at Volcano

September 30, 2014 by Alexander Soule

Activist investor erupts at Volcano

A California activist investor upped its pressure on Volcano yesterday, scolding the company for its $115 million AtheroMed acquisition and missing chances to sell itself at a premium, and threatening a move to oust chairman Ron Matricaria and CEO Scott Huennekens.

San Diego-based Volcano makes precision-guided medical devices, including intravascular ultrasound systems to gauge potential blockages in blood vessels, and functional measurement guidewires to analyze pressure and flow parameters from inside a vessel. Read more

Filed Under: Food & Drug Administration (FDA), News Well, Wall Street Beat Tagged With: Alimera Sciences, Boston Scientific, Echo Therapeutics Inc., Engaged Capital, Leerink Partners, Orthofix, pSivida Corp., stjudemedical, Volcano Corp.

In case you missed it

  • Natus Medical issues field safety notice for snap electrode leads
  • J&J’s Ethicon gets to substitute 20 new claims on surgical stapler patent
  • Minerva Surgical raises $10m
  • Leo Pharma, Portal Instruments partner to develop needle-free drug delivery device
  • Orthofix names new president of global spine business
  • J&J Vision launches Tecnis Toric II intraocular lens in U.S.
  • NOUS Imaging picks up $6.6m for brain-imaging software
  • MicroVention issues safety notice for Azur endovascular embolization products
  • Study reveals long-term outcomes of Boston Scientific Watchman patients
  • 3M issues safety notice for Durapore Advanced surgical tape
  • FDA clearance positions Sight Diagnostics to deliver on two-drop blood testing promise
  • TransMedics touts first U.S. ‘reanimated’ heart transplants
  • Micro-Leads collects $10m for neuromod therapy
  • Viant to cease ethylene oxide sterilization at Michigan plant by year’s end
  • Venclose closes $27m Series C
  • CSA Medical wins CE Mark approval for RejuvenAir System
  • N2 Biomedical appoints new chief financial officer

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS